Peptides inhibiting the oncogenic action of p21 ras

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 11, 514 14, 514 15, 514 16, 514 17, 514 18, 530317, 530326, 530327, 530328, 530329, 530330, 530331, A61K 3812, C07K 508

Patent

active

058406832

ABSTRACT:
The present invention provides peptides and cyclized peptides which inhibit the oncogenic and/or transforming activity of the p21 ras protein, pharmaceutical compositions containing at least one of the ras-inhibiting peptides, cyclized peptides and peptidomimetics, and methods for inhibiting the ras-mediated oncogenic and/or transformation process in mammalian cells or tissues.

REFERENCES:
patent: 4699877 (1987-10-01), Cline et al.
patent: 4855406 (1989-08-01), Yanaihara et al.
patent: 5364851 (1994-11-01), Joran
Liwo et al., J. Prot. Chem. vol. 13 No. 2 (May/1994) pp. 237-251.
Dykes et al., J. Biomol. Struct. 9 Dyn. vol. 11 No. 3 (1993) pp. 443-458.
Lee et al., Med. Sci. Res. vol. 18 No. 19 (Oct. 1990) pp. 771-772.
Spatola et al., "Chemistry & Biochemistry of Amino Acids, Peptides and Proteins", vol. 7 (Weinstein Ed. Marcell Dekkea 1953) 284-285; 344-45.
Science, vol. 256 (Apr./1992) p. 441.
Liwo et al., Embase Abstract No. 94142373 (1994).
Dykes et al., Embase Absrac No. 94032058 (1993).
Kohl et al. (1993) Science 260:1934-1937.
James et al. (1993) Science 260:1937-1942.
Chung et al. (1991) Anticancer Res. 11:1373-1378.
Chung et al. (1992) Exp. Cell Res. 203:329-335.
Hu et al. (1995) Science 268:100-102.
Pincus et al. (1992) Ann. Clin. Lab. Sci. U.S. 22:323-342.
Chung et al. (1991) Biochem. Biophys. Res. Comm. 181:1378-1384.
Haspel et al. (1992) Med. Sci. Res. 20:809-811.
Yamasaki et al. (1994) Biochemistry 33:65-73.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptides inhibiting the oncogenic action of p21 ras does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides inhibiting the oncogenic action of p21 ras, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides inhibiting the oncogenic action of p21 ras will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1702156

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.